Xeris Biopharma Holdings XERS
NASDAQ XERS
$9.59 +0.02 (+0.26%)
As of: Oct 1, 2026 · 11:47 AM EDT

Xeris Biopharma Holdings (XERS) EV to CFO (2025 - 2026)

Updated

Xeris Biopharma Holdings' (XERS) EV to CFO came in at 22.14 for Q2 2026, up 20.8% from the prior quarter.

Analysis

Xeris Biopharma Holdings (XERS) EV to CFO (2025 - 2026) Analysis & Trends

For the trailing twelve months through Jun 30, 2026, EV to CFO at Xeris Biopharma Holdings was 16.58; for FY2025, it came in at 41.70.

  • Quarterly EV to CFO has run from a low of 18.32 in Q1 2026 to a high of 118.94 in Q3 2025 over five years.
  • According to Business Quant data, EV to CFO for the three prior quarters was 18.32 (Q1 2026), 41.70 (Q4 2025) and 118.94 (Q3 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Xeris Biopharma Holdings 1.66 Bn 1.22 Bn 79.59 Mn
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 22.14
Mar 31, 2026 18.32
Dec 31, 2025 41.70
Sep 30, 2025 118.94
API Access

Xeris Biopharma Holdings EV to CFO API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=ev-to-cfo&ticker=XERS&period=max&api_key=YOUR_API_KEY